A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults

NCT00701493 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Topiramate oral liquid formulation;Topiramate Sprinkle formulation

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.